2020
DOI: 10.1016/j.jvsv.2019.08.015
|View full text |Cite
|
Sign up to set email alerts
|

A systematic review of venous stents for iliac and venacaval occlusive disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
34
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 66 publications
(39 citation statements)
references
References 42 publications
0
34
0
Order By: Relevance
“…However, evidence supporting endovascular stenting is currently limited to institutional series or meta-analyses. 8 -10 In a single-center study involving 518 non-thrombotic iliac vein lesions and 464 PTS cases, iliocaval stenting completely relieved pain in 62% and swelling in 32% of patients at 5 years following the procedure. 3 In a recent review by Williams et al, symptomatic relief following stenting varied from 60 to 97%, although a meta-analysis could not be executed due to heterogeneous reporting of symptomatic measures.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, evidence supporting endovascular stenting is currently limited to institutional series or meta-analyses. 8 -10 In a single-center study involving 518 non-thrombotic iliac vein lesions and 464 PTS cases, iliocaval stenting completely relieved pain in 62% and swelling in 32% of patients at 5 years following the procedure. 3 In a recent review by Williams et al, symptomatic relief following stenting varied from 60 to 97%, although a meta-analysis could not be executed due to heterogeneous reporting of symptomatic measures.…”
Section: Discussionmentioning
confidence: 99%
“…3 In a recent review by Williams et al, symptomatic relief following stenting varied from 60 to 97%, although a meta-analysis could not be executed due to heterogeneous reporting of symptomatic measures. 9 Given heterogeneity in stenting outcomes, the ongoing Chronic Venous Thrombosis: Relief with Adjunctive Catheter-Directed Therapy (C-TRACT) trial, a multi-center, phase 3 clinical trial supported by the National Institutes of Health, is assessing iliac venous stenting versus non-invasive management in moderate-to-severe PTS. When completed, this study should provide level 1 evidence regarding iliac vein stenting for PTS.…”
Section: Discussionmentioning
confidence: 99%
“…42 While there are innumerable studies reporting excellent patency rates and clinical outcomes following deep vein stenting for IFVO, the quality of evidence is low. [43][44][45] Most available studies are small, retrospective, single-site evaluations. 46 A systematic review conducted by Seager et al identified no randomised controlled trials, cohort studies or case-control studies.…”
Section: Discussionmentioning
confidence: 99%
“…A GRADE assessment 47 demonstrated the quality of the evidence to be "low" for ulcer healing and "very low" for other outcomes. 44 Despite the weak quality of evidence, deep vein stenting is relatively effective and safe with low incidence of peri-operative complications and high patency rates, 9,[43][44][45][46] and should be considered as a treatment option while the evidence base improves. 44 Post-operative anticoagulation decreases complication rates such as in-stent thrombosis.…”
Section: Discussionmentioning
confidence: 99%
“…Post-thrombotic syndrome (PTS) is a common complication of deep vein thrombosis (DVT) and a major cause of morbidity and healthcare costs (Williams and Dillavou 2020 ). For PTS secondary to chronic iliocaval thrombosis in which standard endovascular reconstruction techniques fail to cross the occlusion, sharp recanalization has been reported with high technical success (McDevitt et al 2019 ; Hage et al 2018 ; Ito et al 2012 ; Wadhwa et al 2018 ).…”
Section: Introductionmentioning
confidence: 99%